First Time Loading...

Evolent Health Inc
NYSE:EVH

Watchlist Manager
Evolent Health Inc Logo
Evolent Health Inc
NYSE:EVH
Watchlist
Price: 27.24 USD 0.52% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one EVH stock under the Base Case scenario is 47.9 USD. Compared to the current market price of 27.24 USD, Evolent Health Inc is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EVH Relative Value
Base Case
47.9 USD
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
66
vs Industry
57
Median 3Y
2.3
Median 5Y
1.8
Industry
2.4
Forward
1.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-54.3
Median 5Y
-25.5
Industry
23.4
Forward
23.3
More Details
21.8
P/OCF
P/OCF
Price to OCF
21.8
vs History
50
vs Industry
20
Median 3Y
34.7
Median 5Y
21.9
Industry
15.5
More Details
11.6
P/FCFE
P/FCFE
Price to FCFE
11.6
vs History
34
vs Industry
32
Median 3Y
11.6
Median 5Y
-5.4
Industry
23.2
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
57
vs Industry
36
Median 3Y
3.1
Median 5Y
2.7
Industry
2.3
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
58
vs Industry
52
Median 3Y
2.4
Median 5Y
2
Industry
2.5
Forward
1.4
More Details
7.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.6
vs History
63
vs Industry
30
Median 3Y
9.6
Median 5Y
8.4
Industry
5.3
More Details
25.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.7
vs History
63
vs Industry
12
Median 3Y
56.3
Median 5Y
42.8
Industry
12.6
Forward
13.7
More Details
274
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
274
vs History
17
vs Industry
1
Median 3Y
-39.1
Median 5Y
-12.5
Industry
17.2
Forward
21.8
More Details
24.6
EV/OCF
EV/OCF
Enterprise Value to OCF
24.6
vs History
50
vs Industry
18
Median 3Y
39.4
Median 5Y
24.6
Industry
15.3
More Details
30.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.8
vs History
26
vs Industry
17
Median 3Y
-15.2
Median 5Y
-15.2
Industry
19.8
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
60
vs Industry
48
Median 3Y
1.9
Median 5Y
1.6
Industry
2
More Details

Multiples Across Competitors

EVH Competitors Multiples
Evolent Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.8 25.7 274
US
Veeva Systems Inc
NYSE:VEEV
32.8B USD 13.9 62.3 62.2 66.9
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.7B AUD 79.9 167.6 115.3 115.3
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.9 -350.7 -185.9 -172.8
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.6B USD 9.8 33.3 22.3 23.8
SE
Sectra AB
STO:SECT B
42.8B SEK 26.1 100.7 -66.3 -66.3
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.9B USD 3.9 -332 35.4 -115.7
US
Certara Inc
NASDAQ:CERT
2.8B USD 8 -50.9 46.1 462.6
P/E Multiple
Earnings Growth
US
Evolent Health Inc
NYSE:EVH
Average P/E: 72.6
Negative Multiple: -21.8 		N/A
US
Veeva Systems Inc
NYSE:VEEV
62.3
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
167.6
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -350.7 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
33.3
79%
SE
Sectra AB
STO:SECT B
100.7
56%
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -332 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Evolent Health Inc
NYSE:EVH
Average EV/EBITDA: 39.5
25.7
194%
US
Veeva Systems Inc
NYSE:VEEV
62.2
211%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
115.3
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -185.9 N/A
JP
M3 Inc
TSE:2413
12.5
24%
US
Doximity Inc
NYSE:DOCS
22.3
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.3 N/A
US
Goodrx Holdings Inc
NASDAQ:GDRX
35.4
305%
US
Certara Inc
NASDAQ:CERT
46.1
143%
EV/EBIT Multiple
EBIT Growth
US
Evolent Health Inc
NYSE:EVH
Average EV/EBIT: 138.4
274
2 086%
US
Veeva Systems Inc
NYSE:VEEV
66.9
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
115.3
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -172.8 N/A
JP
M3 Inc
TSE:2413
14.1
N/A
US
Doximity Inc
NYSE:DOCS
23.8
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.3 N/A
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -115.7 N/A
US
Certara Inc
NASDAQ:CERT
462.6
2 181%

See Also

Summary
EVH intrinsic value, competitors valuation, and company profile.
DCF Valuation
EVH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EVH stock valuation using valuation multiples.
Wall Street Estimates
EVH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EVH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.